A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
- DOI
- 10.1016/s0264-410x(01)00051-2
- Published
- 2001 Apr 30
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0264-410x-01-00051-2,
title = {A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.},
author = {Lambert JS and Keefer M and Mulligan MJ and Schwartz D and Mestecky J and Weinhold K and Smith C and Hsieh R and Moldoveanu Z and Fast P and Forrest B and Koff W},
year = {2001},
journal = {Vaccine},
doi = {10.1016/s0264-410x(01)00051-2},
url = {https://doi.org/10.1016/s0264-410x(01)00051-2}
}RIS
TY - JOUR TI - A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. AU - Lambert JS AU - Keefer M AU - Mulligan MJ AU - Schwartz D AU - Mestecky J AU - Weinhold K AU - Smith C AU - Hsieh R AU - Moldoveanu Z AU - Fast P AU - Forrest B AU - Koff W PY - 2001 JO - Vaccine DO - 10.1016/s0264-410x(01)00051-2 UR - https://doi.org/10.1016/s0264-410x(01)00051-2 ER -
APA
JS, L., M, K., MJ, M., D, S., J, M., K, W., C, S., R, H., Z, M., P, F., B, F., & W, K. (2001). A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.. Vaccine. https://doi.org/10.1016/s0264-410x(01)00051-2
Source records
- pubmed · retrieved 2026-09-27T07:52:13.110Z